1 day Ago By ABMN Staff
Alliancebernstein L.P. cut its stake in shares of Astrana Health, Inc.
( NASDAQ:ASTH – Free Report ) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 50,500 shares of the company’s stock after selling 1,640 shares during the period.
Alliancebernstein L.P.’s holdings in Astrana Health were worth $1,592,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the company. Principal Financial Group Inc. bought a new position in shares of Astrana Health during the third quarter worth approximately $13,383,000.
Franklin Resources Inc. bought a new position in Astrana Health during the 3rd quarter worth $1,187,000. Geode Capital Management LLC bought a new position in Astrana Health during the 3rd quarter worth $58,995,000.
Barclays PLC acquired a new stake in shares of Astrana Health during the third quarter worth $4,457,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Astrana Health by 348.1% in the fourth quarter.
Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company’s stock valued at $1,191,000 after acquiring an additional 29,355 shares during the period. Institutional investors own 52.77% of the company’s stock.
Analyst Upgrades and Downgrades A number of equities analysts recently commented on the stock. Stifel Nicolaus lowered their price target on shares of Astrana Health from $70.00 to $56.
00 and set a “buy” rating on the stock in a research report on Thursday, February 20th. Robert W. Baird lowered their target price on shares of Astrana Health from $86.
00 to $50.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Truist Financial cut their price target on Astrana Health from $50.
00 to $46.00 and set a “buy” rating for the company in a research note on Tuesday, March 18th. Barclays initiated coverage on Astrana Health in a research note on Tuesday, April 1st.
They set an “equal weight” rating and a $36.00 price objective on the stock. Finally, Bank of America dropped their price objective on Astrana Health from $55.
00 to $49.00 and set a “buy” rating for the company in a report on Tuesday, March 4th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company.
According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $53.29.
Astrana Health Trading Down 4.0 % Shares of ASTH stock opened at $31.38 on Friday.
The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.
91. Astrana Health, Inc. has a fifty-two week low of $23.
12 and a fifty-two week high of $63.20. The company has a market cap of $1.
57 billion, a PE ratio of 24.14, a P/E/G ratio of 1.37 and a beta of 1.
04. The stock’s fifty day moving average price is $32.25 and its two-hundred day moving average price is $39.
67. Astrana Health ( NASDAQ:ASTH – Get Free Report ) last posted its earnings results on Thursday, February 27th. The company reported ($0.
15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37).
Astrana Health had a return on equity of 9.37% and a net margin of 3.63%.
The company had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million.
Equities analysts predict that Astrana Health, Inc. will post 1.15 EPS for the current fiscal year.
Astrana Health Company Profile ( Free Report ) Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Stories Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. ( NASDAQ:ASTH – Free Report ).
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter ..
